Additionally, miR-200 (in particular miR-200c) has been shown overexpressed in pancreatic islets in diabetic mice and lead to ß-cell apoptosis through a Zeb1 independent pathway and possibly through Ypel2, a potential oncogene, leading to type 2 diabetes [48]. Here, YPEL2 is linked to type 2 diabetes mellitus.